Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 524

1.

Management of Osteoporosis in Survivors of Adult Cancers With Nonmetastatic Disease: ASCO Clinical Practice Guideline.

Shapiro CL, Van Poznak C, Lacchetti C, Kirshner J, Eastell R, Gagel R, Smith S, Edwards BJ, Frank E, Lyman GH, Smith MR, Mhaskar R, Henderson T, Neuner J.

J Clin Oncol. 2019 Sep 18:JCO1901696. doi: 10.1200/JCO.19.01696. [Epub ahead of print]

PMID:
31532726
2.

Scientific Business Abstracts of the 113th Annual Meeting of the Association of Physicians of Great Britain and Ireland.

Cacciottolo TM, Perikari A, van der Klaauw A, Henning E, Stadler LKJ, Keogh J, Farooqi IS, Tenin G, Keavney B, Ryan E, Budd R, Bewley M, Coelho P, Rumsey W, Sanchez Y, McCafferty J, Dockrell D, Walmsley S, Whyte M, Liu Y, Choy MK, Tenin G, Abraham S, Black G, Keavney B, Ford T, Stanley B, Good R, Rocchiccioli P, McEntegart M, Watkins S, Eteiba H, Shaukat A, Lindsay M, Robertson K, Hood S, McGeoch R, McDade R, Sidik N, McCartney P, Corcoran D, Collison D, Rush C, McConnachie A, Touyz R, Oldroyd K, Berry C, Gazdagh G, Diver L, Marshall J, McGowan R, Ahmed F; DDD Study, Tobias E, Curtis E, Parsons C, Maslin K, D'Angelo S, Moon R, Crozier S, Gossiel F, Bishop N, Kennedy S, Papageorghiou A, Fraser R, Gandhi S, Prentice A, Inskip H, Godfrey K, Schoenmakers I, Javaid MK, Eastell R, Cooper C, Harvey N, Watt ER, Howden A, Mirchandani A, Coelho P, Hukelmann JL, Sadiku P, Plant TM, Cantrell DA, Whyte MKB, Walmsley SR, Mordi I, Forteath C, Wong A, Mohan M, Palmer C, Doney A, Rena G, Lang C, Gray EH, Azarian S, Riva A, Edwards H, McPhail MJW, Williams R, Chokshi S, Patel VC, Edwards LA, Page D, Miossec M, Williams S, Monaghan R, Fotiou E; CHANGE Study Collaborators, CheartED Study Collaborators, Santibanez-Koref M, Keavney B, Badat M, Mettananda S, Hua P, Schwessinger R, Hughes J, Higgs D, Davies J.

QJM. 2019 Sep 1;112(9):724-729. doi: 10.1093/qjmed/hcz175. No abstract available.

PMID:
31505685
3.

Combination denosumab and high dose teriparatide for postmenopausal osteoporosis (DATA-HD): a randomised, controlled phase 4 trial.

Tsai JN, Lee H, David NL, Eastell R, Leder BZ.

Lancet Diabetes Endocrinol. 2019 Oct;7(10):767-775. doi: 10.1016/S2213-8587(19)30255-4. Epub 2019 Aug 22.

PMID:
31447409
4.

Reply to: Change in Bone Density and Reduction in Fracture Risk: A Meta-Regression of Published Trials.

Bouxsein ML, Eastell R, Liu LY, Wu LA, de Papp AE, Grauer A, Marin F, Cauley JA, Bauer DC, Black DM; FNIH Bone Quality Project.

J Bone Miner Res. 2019 Aug 21. doi: 10.1002/jbmr.3837. [Epub ahead of print] No abstract available.

PMID:
31433861
5.

Association Between Drug Treatments for Patients With Osteoporosis and Overall Mortality Rates: A Meta-analysis.

Cummings SR, Lui LY, Eastell R, Allen IE.

JAMA Intern Med. 2019 Aug 19. doi: 10.1001/jamainternmed.2019.2779. [Epub ahead of print]

PMID:
31424486
6.

A Vitamin D, Calcium and Leucine-Enriched Whey Protein Nutritional Supplement Improves Measures of Bone Health in Sarcopenic Non-Malnourished Older Adults: The PROVIDE Study.

Hill TR, Verlaan S, Biesheuvel E, Eastell R, Bauer JM, Bautmans I, Brandt K, Donini LM, Maggio M, Mets T, Seal CJ, Wijers SL, Sieber C, Cederholm T, Aspray TJ; PROVIDE Consortium.

Calcif Tissue Int. 2019 Oct;105(4):383-391. doi: 10.1007/s00223-019-00581-6. Epub 2019 Jul 23.

PMID:
31338563
7.

Continued Beneficial Effects of Burosumab in Adults with X-Linked Hypophosphatemia: Results from a 24-Week Treatment Continuation Period After a 24-Week Double-Blind Placebo-Controlled Period.

Portale AA, Carpenter TO, Brandi ML, Briot K, Cheong HI, Cohen-Solal M, Crowley R, Jan De Beur S, Eastell R, Imanishi Y, Imel EA, Ing S, Ito N, Javaid M, Kamenicky P, Keen R, Kubota T, Lachmann R, Perwad F, Pitukcheewanont P, Ralston SH, Takeuchi Y, Tanaka H, Weber TJ, Yoo HW, Zhang L, Theodore-Oklota C, Mealiffe M, San Martin J, Insogna K.

Calcif Tissue Int. 2019 Sep;105(3):271-284. doi: 10.1007/s00223-019-00568-3. Epub 2019 Jun 4.

PMID:
31165191
8.

Response Letter to the Editor-Diamond et al, JBMR.

Ebeling PR, Akesson K, Bauer DC, Buchbinder R, Eastell R, Fink HA, Giangregorio L, Guanabens N, Kado D, Kallmes D, Katzman W, Rodriguez A, Wermers R, Wilson HA, Bouxsein ML.

J Bone Miner Res. 2019 Jun;34(6):1185-1186. doi: 10.1002/jbmr.3724. Epub 2019 May 28. No abstract available.

PMID:
31135998
9.

A multicenter study to evaluate harmonization of assays for N-terminal propeptide of type I procollagen (PINP): a report from the IFCC-IOF Joint Committee for Bone Metabolism.

Cavalier E, Eastell R, Rye Jørgensen N, Makris K, Tournis S, Vasikaran S, Kanis JA, Cooper C, Pottel H, Morris HA; IFCC-IOF Joint Committee for Bone Metabolism (C-BM).

Clin Chem Lab Med. 2019 Sep 25;57(10):1546-1555. doi: 10.1515/cclm-2019-0174.

PMID:
31085740
10.

Comparison of risedronate versus placebo in preventing anastrozole-induced bone loss in women at high risk of developing breast cancer with osteopenia.

Sestak I, Blake GM, Patel R, Coleman RE, Cuzick J, Eastell R.

Bone. 2019 Jul;124:83-88. doi: 10.1016/j.bone.2019.04.016. Epub 2019 Apr 24.

11.

Response to Letter to the Editor: "Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Clinical Practice Guideline".

Eastell R, Rosen CJ.

J Clin Endocrinol Metab. 2019 Aug 1;104(8):3537-3538. doi: 10.1210/jc.2019-00777. No abstract available.

PMID:
30998238
12.

Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society* Clinical Practice Guideline.

Eastell R, Rosen CJ, Black DM, Cheung AM, Murad MH, Shoback D.

J Clin Endocrinol Metab. 2019 May 1;104(5):1595-1622. doi: 10.1210/jc.2019-00221.

PMID:
30907953
13.

The Efficacy and Safety of Vertebral Augmentation: A Second ASBMR Task Force Report.

Ebeling PR, Akesson K, Bauer DC, Buchbinder R, Eastell R, Fink HA, Giangregorio L, Guanabens N, Kado D, Kallmes D, Katzman W, Rodriguez A, Wermers R, Wilson HA, Bouxsein ML.

J Bone Miner Res. 2019 Jan;34(1):3-21. doi: 10.1002/jbmr.3653.

PMID:
30677181
14.

Change in Bone Density and Reduction in Fracture Risk: A Meta-Regression of Published Trials.

Bouxsein ML, Eastell R, Lui LY, Wu LA, de Papp AE, Grauer A, Marin F, Cauley JA, Bauer DC, Black DM; FNIH Bone Quality Project.

J Bone Miner Res. 2019 Apr;34(4):632-642. doi: 10.1002/jbmr.3641. Epub 2019 Jan 23.

PMID:
30674078
15.

Bone turnover markers to explain changes in lumbar spine BMD with abaloparatide and teriparatide: results from ACTIVE.

Eastell R, Mitlak BH, Wang Y, Hu M, Fitzpatrick LA, Black DM.

Osteoporos Int. 2019 Mar;30(3):667-673. doi: 10.1007/s00198-018-04819-1. Epub 2019 Jan 11.

16.

Clinical utility of bone turnover markers in monitoring the withdrawal of treatment with oral bisphosphonates in postmenopausal osteoporosis.

Naylor KE, McCloskey EV, Jacques RM, Peel NFA, Paggiosi MA, Gossiel F, Walsh JS, Eastell R.

Osteoporos Int. 2019 Apr;30(4):917-922. doi: 10.1007/s00198-018-04823-5. Epub 2019 Jan 6.

PMID:
30613868
17.

Comparison of BMD Changes and Bone Formation Marker Levels 3 Years After Bisphosphonate Discontinuation: FLEX and HORIZON-PFT Extension I Trials.

Kim TY, Bauer DC, McNabb BL, Schafer AL, Cosman F, Black DM, Eastell R.

J Bone Miner Res. 2019 May;34(5):810-816. doi: 10.1002/jbmr.3654. Epub 2019 Jan 15.

PMID:
30536713
18.

Discordant pattern of peripheral fractures in diabetes: a meta-analysis on the risk of wrist and ankle fractures.

Vilaca T, Walsh J, Eastell R.

Osteoporos Int. 2019 Jan;30(1):135-143. doi: 10.1007/s00198-018-4717-0. Epub 2018 Oct 10.

PMID:
30306223
19.

Developing a toolkit for the assessment and monitoring of musculoskeletal ageing.

Kemp GJ, Birrell F, Clegg PD, Cuthbertson DJ, De Vito G, van Dieën JH, Del Din S, Eastell R, Garnero P, Goljanek-Whysall K, Hackl M, Hodgson R, Jackson MJ, Lord S, Mazzà C, McArdle A, McCloskey EV, Narici M, Peffers MJ, Schiaffino S, Mathers JC.

Age Ageing. 2018 Sep 1;47(suppl_4):iv1-iv19. doi: 10.1093/ageing/afy143.

20.

Towards a toolkit for the assessment and monitoring of musculoskeletal ageing.

Kemp GJ, Jackson MJ, McCloskey EV, Mathers JC; CIMA Toolkit Working Group.

Age Ageing. 2018 Nov 1;47(6):774-777. doi: 10.1093/ageing/afy078.

Supplemental Content

Loading ...
Support Center